Context Therapeutics Inc is trading 10.9% down at $2.48 as investors lock in gains following a sharp multi-day rally.
- The stock recently surged from approximately $2.40 to highs near the upper $2 range, leading to a period of short-term profit-taking and consolidation.
- There are no fresh company-specific announcements or broader sector shocks reported for June 2, 2026, suggesting the move is driven by technical corrections after recent strength.